Finally, studies using an atherosclerosis/lupus-prone mouse model showed that anti-BAFF treatment improved atherosclerosis lesions in mice with low plasma cholesterol levels, but worsened the lesions in counterparts with high cholesterol levels [21]. Here, TNFSF13B is linked to systemic lupus erythematosus.